STAT

Opinion: I get asked a lot about longevity. It helps that I’m 104

As scientists pursue longevity and anti-aging research, we wanted to hear from a centenarian on her life experience and thoughts on aging. So we called one.

As scientists pursue longevity and anti-aging research, and as more people are living to 100, we wanted to hear from a centenarian on her life experience and thoughts on aging. STAT editor Sarah Mupo spoke with 104-year-old Missouri resident Virginia Leitner. Their conversation forms the basis for this brief oral history.

When anyone meets me for the first

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A GLP-1 Side Effect, U.K. Clinical Trial Transparency, And More
A new study links GLP-1 drugs like Ozempic to a higher risk of aspiration pneumonia — a lung infection caused by food breathed into the lungs — after endoscopies.
STAT1 min read
STAT+: Medicare Expected To Negotiate Obesity Drug Prices Soon, New Analysis Predicts
Medicare will likely choose the obesity drug semaglutide for price negotiation “within the next few years,” according to a new analysis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An AstraZeneca Deal, A WHO Pandemic Pact, And More
AstraZeneca agreed to acquire Fusion Pharmaceuticals in a deal worth more than $2 billion, picking up a company focused on targeted radiation therapies for cancer.

Related Books & Audiobooks